These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36313690)

  • 1. Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer.
    Cheng H; Yang J; Fu X; Mao L; Chu X; Lu C; Li G; Qiu Y; He W
    Front Oncol; 2022; 12():1012609. PubMed ID: 36313690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-targeted polymerase chain reaction for the detection of folate receptor-positive circulating tumour cells as a potential diagnostic biomarker for pancreatic cancer.
    Cheng H; He W; Yang J; Ye Q; Cheng L; Pan Y; Mao L; Chu X; Lu C; Li G; Qiu Y; He J
    Cell Prolif; 2020 Sep; 53(9):e12880. PubMed ID: 32707596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study.
    Zhou Q; He Q; He W; Wang C; Liu G; Wang K; Li H; Li J; Xiao W; Fang Q; Peng L; Han Y; Wang D; Leng X
    BMC Cancer; 2023 Nov; 23(1):1171. PubMed ID: 38037003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients.
    Li H; Li B; Pan Y; Zhang Y; Xiang J; Zhang Y; Sun Y; Yu X; He W; Hu H
    Front Oncol; 2020; 10():621435. PubMed ID: 33585249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Folate Receptor-Positive Circulating Tumor Cells Are Associated With Occult Peritoneal Metastasis and Early Recurrence in Gastric Cancer Patients: A Prospective Cohort Study.
    Zeng CDD; Jin CC; Gao C; Xiao AT; Tong YX; Zhang S
    Front Oncol; 2022; 12():769203. PubMed ID: 35425708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma.
    Hugenschmidt H; Labori KJ; Brunborg C; Verbeke CS; Seeberg LT; Schirmer CB; Renolen A; Borgen EF; Naume B; Wiedswang G
    Ann Surg; 2020 Mar; 271(3):549-558. PubMed ID: 30216219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells can predict the prognosis of patients with non-small cell lung cancer after resection: a retrospective study.
    Li Z; Xu K; Tartarone A; Santarpia M; Zhu Y; Jiang G
    Transl Lung Cancer Res; 2021 Feb; 10(2):995-1006. PubMed ID: 33718038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate receptor-positive circulating tumor cells as a predictive biomarker for the efficacy of first-line pemetrexed-based chemotherapy in patients with non-squamous non-small cell lung cancer.
    Chen X; Zhou F; Li X; Yang G; Zhao C; Li W; Wu F; Yu J; Gao G; Li J; Li A; Ren S; Zhou C
    Ann Transl Med; 2020 May; 8(10):631. PubMed ID: 32566568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of postoperative folate receptor-positive circulating tumor cells (FR + CTCs) for long-term prognosis in patients with invasive adenocarcinoma (IAC) of the lung.
    Ma Z; Zhou Z; Wang S; Ji H; Zhao D; Wang L; Chen J
    Thorac Cancer; 2024 May; 15(13):1060-1071. PubMed ID: 38532562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
    BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative CTC-Detection by CellSearch
    Hugenschmidt H; Labori KJ; Borgen E; Brunborg C; Schirmer CB; Seeberg LT; Naume B; Wiedswang G
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33513877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.
    Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C
    Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial heterogeneity in epithelial to mesenchymal transition properties of circulating tumor cells associated with distant recurrence in pancreatic cancer patients.
    Dong X; Ma Y; Zhao X; Tian X; Sun Y; Yang Y; Zhao X
    Ann Transl Med; 2020 Jun; 8(11):676. PubMed ID: 32617296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative levels of folate receptor-positive circulating tumor cells in different subtypes of early-stage lung adenocarcinoma: Predictive value for determining extent of surgical resection.
    Zhou C; Zhao R; Zhao R; Wang A; Li W
    Front Oncol; 2023; 13():1119807. PubMed ID: 37139152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer.
    Wang L; Wu C; Qiao L; Yu W; Guo Q; Zhao M; Yang G; Zhao H; Lou J
    J Cancer; 2017; 8(1):104-110. PubMed ID: 28123603
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of colorectal cancer liver metastases based on liquid biopsy combined with folate receptor- Positive circulating tumor cells and HSP90.
    Huang M; Cheng L; Mo S; Ru H; Mo X; Yan L
    Front Oncol; 2022; 12():912016. PubMed ID: 36203415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of folate receptor-positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics.
    Xu Y; Li Q; Lin Z; Lin Y
    Clin Respir J; 2023 May; 17(5):374-383. PubMed ID: 36977421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial.
    Arrazubi V; Mata E; Antelo ML; Tarifa A; Herrera J; Zazpe C; Teijeira L; Viudez A; Suárez J; Hernández I; Vera R
    Ann Surg Oncol; 2019 Sep; 26(9):2805-2811. PubMed ID: 31209673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells detected only after surgery for non-small cell lung cancer: is it a predictor of recurrence?
    Sawabata N; Nakamura T; Kawaguchi T; Watanabe T; Ouji NS; Ito T; Taniguchi S
    J Thorac Dis; 2020 Sep; 12(9):4623-4632. PubMed ID: 33145035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.
    Bayarri-Lara C; Ortega FG; Cueto Ladrón de Guevara A; Puche JL; Ruiz Zafra J; de Miguel-Pérez D; Ramos AS; Giraldo-Ospina CF; Navajas Gómez JA; Delgado-Rodriguez M; Lorente JA; Serrano MJ
    PLoS One; 2016; 11(2):e0148659. PubMed ID: 26913536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.